TODD LASCO to Recombinant Fusion Proteins
This is a "connection" page, showing publications TODD LASCO has written about Recombinant Fusion Proteins.
Connection Strength
0.017
-
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine. 2010 Jan 22; 28(4):1084-93.
Score: 0.017
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.